自体移植物抗宿主病？ - Suppr | 超能文献

相似文献

1

Autologous GVHD?自体移植物抗宿主病？

Bone Marrow Transplant. 2014 Nov;49(11):1349-51. doi: 10.1038/bmt.2014.169. Epub 2014 Aug 4.

2

Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia.含阿仑单抗预处理方案及自体干细胞移植治疗慢性淋巴细胞白血病后出现的自体移植物抗宿主病样综合征

Blood. 2006 Sep 15;108(6):2127-30. doi: 10.1182/blood-2006-04-007898. Epub 2006 May 25.

3

Late recurrence of autologous GvHD in a myeloma patient: a myth or diagnostic challenge?骨髓瘤患者自体移植物抗宿主病的晚期复发：虚构之事还是诊断挑战？

Bone Marrow Transplant. 2017 Jun;52(6):910-912. doi: 10.1038/bmt.2017.20. Epub 2017 Mar 20.

4

Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma.高危淋巴瘤患者接受序贯大剂量化疗联合自体干细胞移植，随后进行减低剂量异基因干细胞移植的II期试验。

Biol Blood Marrow Transplant. 2015 Sep;21(9):1583-8. doi: 10.1016/j.bbmt.2015.05.016. Epub 2015 May 22.

5

Immunoselection techniques in hematopoietic stem cell transplantation.造血干细胞移植中的免疫选择技术。

Transfus Apher Sci. 2016 Jun;54(3):356-63. doi: 10.1016/j.transci.2016.05.012. Epub 2016 May 12.

6

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.造血干细胞移植操作作为一种免疫治疗机制。

Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6.

7

Graft-versus-host disease in stem cell transplantation.干细胞移植中的移植物抗宿主病

Duodecim. 2017;133(3):251-8.

8

Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.利用分选的CD34(+)细胞增强外周血干细胞移植后环孢素A诱导的自体移植物抗宿主病

Bone Marrow Transplant. 2003 Oct;32(8):785-90. doi: 10.1038/sj.bmt.1704208.

9

Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy.应用数字显微镜评估异基因或自体干细胞移植后急性期外周血裂片细胞。

Int J Lab Hematol. 2020 Apr;42(2):145-151. doi: 10.1111/ijlh.13130. Epub 2019 Nov 26.

10

Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma.高供体CD3+细胞剂量对高危骨髓瘤串联自体-非清髓性异基因移植后结局的不良影响。

Bone Marrow Transplant. 2017 Jun;52(6):839-845. doi: 10.1038/bmt.2017.37. Epub 2017 Mar 20.

引用本文的文献

1

mTEC damage risks immune recovery.mTEC 损伤会增加免疫恢复风险。

J Exp Med. 2022 Feb 7;219(2). doi: 10.1084/jem.20212326. Epub 2021 Dec 17.

2

Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy.病例报告：自体间充质干细胞治疗后出现毛细血管渗漏综合征伴肾移植失败

Front Med (Lausanne). 2021 Jul 21;8:708744. doi: 10.3389/fmed.2021.708744. eCollection 2021.

3

Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.

本文引用的文献

1

'A rose by any other name would smell as sweet', or would it?“玫瑰换个名字也同样芬芳”，果真如此吗？

Bone Marrow Transplant. 2013 Jul;48(7):881-3. doi: 10.1038/bmt.2012.275. Epub 2013 Feb 4.

2

Interpreting incremental value of markers added to risk prediction models.解读风险预测模型中新增标志物的增量价值。

Am J Epidemiol. 2012 Sep 15;176(6):473-81. doi: 10.1093/aje/kws207. Epub 2012 Aug 8.

3

Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.造血干细胞移植后 28 至 84 天期间接受移植者的角质形成细胞发育不良。